Preventative effects of morinda citrifolia on mammary breast cancer
The present invention features a novel use of processed ingredients from the Indian mulberry plant. More specifically, the present invention features a novel use of processed Morinda citrifolia , namely Morinda citrifolia fruit juice, puree, or puree juice for treating breast cancer, and particularly for inhibiting and/or preventing the metastasis of carcinogenic cells within the mammary region of the breast, as well as destroying metastasized mammary or breast cancer cells. The present invention comprises the consumption of food products or medicinal products or compositions comprising processed Morinda citrifolia , in either puree or fruit juice form. The present invention also features a method of inhibiting carcinogen-mediated conversion of mammary cells and protecting DNA against carcinogen-mediated damage by administering a composition comprising water soluble Morinda citrifolia.
1 . A method for inhibiting carcinogen-mediated conversion of mammary gland cells to cancer, comprising the steps of:
administering to a patient an oral composition comprising processed Morinda citrifolia fruit juice.
2 . A method as in claim 1 , wherein said administering further comprises administering 100 percent processed Morinda citrifolia fruit juice twice daily in an eight ounce bolus.
3 . A method for treating mammary breast cancer, said method comprising the steps of:
adding a processed Morinda citrifolia product to an alcohol-based solution;
isolating and extracting an active ingredient of Morinda citrifolia from said solution;
administering said extracted active ingredient to a patient, wherein said extracted active ingredient inhibits, prevents, and destroys the growth of carcinogenic cells.
4 . The method of claim 3 , wherein said processed Morinda citrifolia product comprises processed Morinda citrifolia fruit juice.
5 . The method of claim 3 , wherein said processed Morinda citrifolia product comprises processed Morinda citrifolia puree.
6 . The method of claim 3 , wherein said processed Morinda citrifolia product comprises processed Morinda citrifolia puree juice.
7 . The method of claim 3 , wherein said alcohol-based solution is selected from the group consisting essentially of methanol, ethanol, and ethyl acetate, and other alcohol-based derivatives.
8 . A method for inhibiting, preventing, and destroying carcinogenic cells within the mammary region of the breast, said method comprising the steps of:
orally administering at least one ounce of a food product comprising processed Morinda citrifolia fruit juice on an empty stomach in the morning; and
orally administering at least one ounce of said food product prior to sleeping at night.
9 . The method of claim 8 , wherein said food product comprises:
processed Morinda citrifolia fruit juice present in an amount by weight of about 100 percent.
10 . The method of claim 8 , wherein said food product comprises:
processed Morinda citrifolia fruit juice present in an amount by weight between about 85-99.99 percent; and
water present in an amount by weight between about 0.1-15 percent.
11 . The method of claim 8 , wherein said food product comprises:
processed Morinda citrifolia fruit juice present in an amount by weight between about 85-99.99 percent; and
other fruit juices present in an amount by weight between about 0.1-15 percent.
12 . The method of claim 8 , wherein said food product comprises:
processed Morinda citrifolia fruit juice present in an amount by weight between about 50-90 percent;
water present in an amount by weight between about 0.1-50 percent; and
other fruit juices present in an amount between about 0.1-30 percent.
13 . The method of claim 8 , wherein said orally administering further comprises orally administering to said patient two ounces of said food product, twice daily.
14 . A composition for inhibiting carcinogen-mediated conversion of mammary gland cells to melanomas, comprising Morinda citrifolia fruit juice.
15 . The composition of claim 15 , wherein said Morinda citrifolia fruit juice comprises about 100 percent of said composition.
16 . The composition of claim 15 , wherein said Morinda citrifolia fruit juice is present in an amount between about 85.0 to 99.9 percent by composition weight, and wherein said composition further comprises water present in an amount between about 0.1 to 15 percent by composition weight.
17 . The composition of claim 15 , wherein said Morinda citrifolia fruit juice is present in an amount between about 85.0 to 99.99 percent by composition weight, and wherein said composition further comprises other fruit juices in an amount between about 0.1 to 15.0 percent by composition weight.
18 . The composition of claim 15 , wherein said Morinda citrifolia fruit juice is present in an amount between about 50 to 90 percent by composition weight, and wherein said composition further comprises water in an amount between about 0.1 to 50 percent by composition weight and other fruit juices in an amount between about 0.1 to 30 percent by composition weight.
19 . The method of claim 1 , wherein said administering further comprises administering Morinda citrifolia fruit juice in a 5 percent solution three times a day for 90 days.